<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Conventional wisdom states that associations between fetal growth and diseases in pregnancy, such as pregnancy-induced <z:hpo ids='HP_0000822'>hypertension</z:hpo> (PIH) and <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e>), result from effects of the mother's genotype or environment acting on her <z:mp ids='MP_0001532'>physiology</z:mp> which subsequently affect the fetus </plain></SENT>
<SENT sid="1" pm="."><plain>However, recent evidence from human mothers carrying macrosomic offspring with <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith Wiedemann syndrome</z:e> and pregnant mice carrying p57(kip2)-null offspring suggest that variation in the fetal genome can modify maternal <z:mp ids='MP_0001532'>physiology</z:mp> to increase fetal nutrient delivery and optimise growth </plain></SENT>
<SENT sid="2" pm="."><plain>These are some of the first documented examples of such effects, whereby the genome of one individual directly affects the <z:mp ids='MP_0001532'>physiology</z:mp> of another related individual from the same species </plain></SENT>
<SENT sid="3" pm="."><plain>We propose that this mechanism is involved in the aetiology of PIH and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> </plain></SENT>
</text></document>